Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults

NCT ID: NCT07196514

Last Updated: 2026-01-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-06

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Curcumin (a bioactive compound found in turmeric) has demonstrated anti-inflammatory and antioxidant properties, and there is evidence to suggest that it may produce improvements in quality of life and markers of health in humans with various conditions. To date, the research has often focussed on the effects of curcumin in human participants with a particular condition. However, turmeric contains hundreds of other bioactive compounds (including other curcuminoids and essential oils) and may be able to benefit a wide range of older adults. Therefore, the aim of this study is to investigate the effects of twice daily consumption of a turmeric beverage for 8-weeks on the physiology and wellbeing of older adults (versus placebo).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Turmeric Placebo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

This group will take one placebo shot (containing a small amount of turmeric for taste-matching purposes) twice per day for 8 weeks.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

This group will take one placebo shot (containing a small amount of turmeric for taste-matching purposes) twice per day for 8 weeks.

Turmeric

This group will take one 60 mL commercially-available shot (containing 30% turmeric) twice per day for 8 weeks.

Group Type EXPERIMENTAL

Raw turmeric shots

Intervention Type DIETARY_SUPPLEMENT

This group will take one 60 mL commercially-available shot (containing 30% turmeric) twice per day for 8 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Raw turmeric shots

This group will take one 60 mL commercially-available shot (containing 30% turmeric) twice per day for 8 weeks.

Intervention Type DIETARY_SUPPLEMENT

Placebo

This group will take one placebo shot (containing a small amount of turmeric for taste-matching purposes) twice per day for 8 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Body Mass Index between 18.5-39.9.

Exclusion Criteria

* History of, or currently diagnosed with, a cardiovascular disease.
* Diagnosed with diabetes.
* Diagnosed with a liver, lung, or kidney disease.
* Diagnosed with osteoporosis.
* Diagnosed with dementia.
* Diagnosed with cancer.
* Use of medications/supplements/herbal remedies with human evidence of a significant interaction with turmeric.
* Allergy to turmeric, lemon, black pepper, watermelon, water, pineapple, magnesium or vitamin C.
* Pregnant, attempting to become pregnant, or breastfeeding.
* Regular (once per week or more) use of turmeric shots / supplements within the last 3 months.
Minimum Eligible Age

40 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Innate-Essence Limited

UNKNOWN

Sponsor Role collaborator

Nottingham Trent University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

John Hough

Associate Professor in Health and Immunology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nottingham Trent University, Clifton campus

Nottingham, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

John Hough

Role: primary

+441158483970

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2268061

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.